The cannabis industry received a significant boost this week as the Justice Department reclassified state-licensed marijuana products from Schedule I to Schedule III, a less restrictive category. This change, primarily affecting medical marijuana, could revive investor interest in cannabis stocks and ETFs, as evidenced by the AdvisorShares Pure U.S. Cannabis ETF (MSOS), which surged over 6% in mid-morning trading on Friday.
The reclassification is crucial for the cannabis sector, which has struggled with limited access to banking and high tax burdens due to its federal status. While the initial impact is focused on medical use, the DOJ has scheduled a June hearing to discuss the potential reclassification of recreational marijuana, signaling a broader shift that could enhance market dynamics. This news may lead to increased demand and investment opportunities within the industry.
For market professionals, the DOJ’s actions suggest a pivotal moment for cannabis investments, making it an opportune time to reassess positions in cannabis-related assets as regulatory barriers begin to ease.
Source: fool.com